Insider Transactions in Q3 2022 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2022
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
14,855
-100.0%
|
$341,665
$23.07 P/Share
|
|
Aug 25
2022
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,855
+50.0%
|
$14,855
$1.24 P/Share
|
|
Aug 24
2022
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
35,045
-100.0%
|
$770,990
$22.8 P/Share
|
|
Aug 24
2022
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,045
+50.0%
|
$35,045
$1.24 P/Share
|
|
Aug 16
2022
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
3,499
-72.46%
|
$76,978
$22.08 P/Share
|
|
Aug 16
2022
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,499
+42.01%
|
$3,499
$1.24 P/Share
|
|
Aug 15
2022
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
62,498
-97.92%
|
$1,374,956
$22.12 P/Share
|
|
Aug 15
2022
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62,498
+42.04%
|
$0
$0.89 P/Share
|
|
Aug 15
2022
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
100
-100.0%
|
$2,200
$22.47 P/Share
|
|
Aug 15
2022
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+50.0%
|
$100
$1.24 P/Share
|
|
Aug 12
2022
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
14,003
-91.33%
|
$308,066
$22.0 P/Share
|
|
Aug 12
2022
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,003
+47.73%
|
$0
$0.53 P/Share
|